Bryn Mawr Capital Management LLC Has $5.25 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bryn Mawr Capital Management LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 618.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,065 shares of the medical equipment provider's stock after acquiring an additional 8,665 shares during the quarter. Bryn Mawr Capital Management LLC's holdings in Intuitive Surgical were worth $5,254,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Alberta Investment Management Corp acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $15,291,000. Global Retirement Partners LLC increased its position in shares of Intuitive Surgical by 11.5% in the fourth quarter. Global Retirement Partners LLC now owns 11,994 shares of the medical equipment provider's stock valued at $6,260,000 after acquiring an additional 1,238 shares during the last quarter. Chapman Investment Management LLC increased its position in shares of Intuitive Surgical by 5.7% in the fourth quarter. Chapman Investment Management LLC now owns 2,174 shares of the medical equipment provider's stock valued at $1,135,000 after acquiring an additional 117 shares during the last quarter. Klingman & Associates LLC increased its position in shares of Intuitive Surgical by 7.6% in the fourth quarter. Klingman & Associates LLC now owns 780 shares of the medical equipment provider's stock valued at $407,000 after acquiring an additional 55 shares during the last quarter. Finally, Kornitzer Capital Management Inc. KS increased its position in shares of Intuitive Surgical by 0.7% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 5,814 shares of the medical equipment provider's stock valued at $3,035,000 after acquiring an additional 39 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the business's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,348 shares of company stock worth $3,587,582. Company insiders own 0.90% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ISRG. Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price target for the company. BTIG Research lifted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Bernstein Bank lifted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. Finally, Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $14.78 during trading on Friday, hitting $591.79. The company had a trading volume of 1,673,828 shares, compared to its average volume of 1,567,754. The firm has a market capitalization of $210.78 billion, a P/E ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The stock's 50-day moving average price is $565.45 and its 200 day moving average price is $525.06. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.